Your browser doesn't support javascript.
loading
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Peterlongo, Paolo; Chang-Claude, Jenny; Moysich, Kirsten B; Rudolph, Anja; Schmutzler, Rita K; Simard, Jacques; Soucy, Penny; Eeles, Rosalind A; Easton, Douglas F; Hamann, Ute; Wilkening, Stefan; Chen, Bowang; Rookus, Matti A; Schmidt, Marjanka K; van der Baan, Frederieke H; Spurdle, Amanda B; Walker, Logan C; Lose, Felicity; Maia, Ana-Teresa; Montagna, Marco; Matricardi, Laura; Lubinski, Jan; Jakubowska, Anna; Gómez Garcia, Encarna B; Olopade, Olufunmilayo I; Nussbaum, Robert L; Nathanson, Katherine L; Domchek, Susan M; Rebbeck, Timothy R; Arun, Banu K; Karlan, Beth Y; Orsulic, Sandra; Lester, Jenny; Chung, Wendy K; Miron, Alex; Southey, Melissa C; Goldgar, David E; Buys, Saundra S; Janavicius, Ramunas; Dorfling, Cecilia M; van Rensburg, Elizabeth J; Ding, Yuan Chun; Neuhausen, Susan L; Hansen, Thomas V O; Gerdes, Anne-Marie; Ejlertsen, Bent; Jønson, Lars; Osorio, Ana; Martínez-Bouzas, Cristina; Benitez, Javier.
Afiliação
  • Peterlongo P; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy. paolo.peterlongo@ifom.eu eitan.friedman@sheba.health.go
  • Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Moysich KB; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.
  • Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schmutzler RK; Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, University Hospital Cologne, Germany. Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Germany. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Germany, on behalf of the German C
  • Simard J; Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Canada.
  • Soucy P; Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Canada.
  • Eeles RA; Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Surrey, United Kingdom.
  • Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Wilkening S; Genomic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Chen B; Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Rookus MA; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Schmidt MK; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van der Baan FH; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Spurdle AB; Department of Genetics and Computational Biology, QIMR Berghofer, Brisbane, Australia.
  • Walker LC; Department of Pathology, University of Otago, Christchurch, New Zealand.
  • Lose F; Department of Genetics and Computational Biology, QIMR Berghofer, Brisbane, Australia.
  • Maia AT; Department of Biomedical Sciences and Medicine, Gambelas Campus, University of Algarve, Portugal.
  • Montagna M; Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy.
  • Matricardi L; Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy.
  • Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Gómez Garcia EB; Department of Clinical Genetics, MUMC, Maastricht, the Netherlands.
  • Olopade OI; Center for Clinical Cancer Genetics, Department of Medicine and Human Genetics, University of Chicago Medical Center, Chicago, Illinois.
  • Nussbaum RL; Department of Medicine and Institute for Human Genetics, University of California, San Francisco, San Francisco, California.
  • Nathanson KL; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadephia, Pennsylvania.
  • Domchek SM; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadephia, Pennsylvania.
  • Rebbeck TR; Department of Epidemiology and Biostatistics, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadephia, Pennsylvania.
  • Arun BK; University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Karlan BY; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Orsulic S; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Lester J; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Chung WK; Departments of Pediatrics and Medicine, Columbia University, New York, New York.
  • Miron A; Department of Genetics and Genomics at Case Western Reserve Medical School, Cleveland, Ohio.
  • Southey MC; Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Australia.
  • Goldgar DE; Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah.
  • Buys SS; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah.
  • Janavicius R; Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology, and Transfusion Medicine Center, Dept. of Molecular and Regenerative Medicine; State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.
  • Dorfling CM; Department of Genetics, University of Pretoria, Pretoria, South Africa.
  • van Rensburg EJ; Department of Genetics, University of Pretoria, Pretoria, South Africa.
  • Ding YC; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California.
  • Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California.
  • Hansen TV; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Gerdes AM; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Ejlertsen B; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Jønson L; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Osorio A; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain.
  • Martínez-Bouzas C; Molecular Genetics Laboratory, Department of Biochemistry, Cruces Hospital Barakaldo, 48903-Barakaldo-Bizkaia, Spain.
  • Benitez J; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. Human Genetics Group and Genotyping Unit, Spanish National Cancer Centre (CNIO), Madrid, Spain.
Cancer Epidemiol Biomarkers Prev ; 24(1): 308-16, 2015 Jan.
Article em En | MEDLINE | ID: mdl-25336561
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / Genes BRCA1 / Genes BRCA2 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / Genes BRCA1 / Genes BRCA2 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article